# Safety and Efficacy of Buprenorphine Transdermal System in Subjects With Moderate to Severe Osteoarthritis of Hip or Knee

> **NCT00313846** · PHASE3 · COMPLETED · sponsor: **Purdue Pharma LP** · enrollment: 529 (actual)

## Conditions studied

- Osteoarthritis

## Interventions

- **DRUG:** Buprenorphine transdermal patch
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00313846
- **Lead sponsor:** Purdue Pharma LP
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-04
- **Primary completion:** 2004-06
- **Final completion:** 2004-06
- **Target enrollment:** 529 (ACTUAL)
- **Last updated:** 2012-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00313846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00313846, "Safety and Efficacy of Buprenorphine Transdermal System in Subjects With Moderate to Severe Osteoarthritis of Hip or Knee". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00313846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*